Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 Next >
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags Business Stock markets Breaking News: Markets
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags Finance Markets Market Insider
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags Biogen Inc Social issues Biotech and Pharmaceuticals
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags Social issues Biotechnology Biogen Inc
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags stocks Breaking News: Markets Stock markets
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags Disease outbreaks Science World News
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags US Economy US: News Social issues
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags stocks Stock markets TJX Companies Inc
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags U/S/ Economy Eisai Co Ltd Eli Lilly and Co
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Biogen Inc Chegg Inc Match Group Inc
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags Health care industry Eisai Co Ltd U/S/ Economy
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags Policy Health care industry Eli Lilly and Co
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags Health & Science Breaking News: Business Business News
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Health care industry Eli Lilly and Co Eisai Co Ltd
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
Tags Ionis Pharmaceuticals Inc Breaking news Pharmaceuticals
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Breaking news Pharmaceuticals Science
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Science Breaking news Pharmaceuticals
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
Tags Biotech and Pharmaceuticals Breaking News: Business Health & Science
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
Tags Biotech and Pharmaceuticals Health care industry Business News
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags Health & Science Breaking News: Business Business News
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags Biotechnology Biogen Inc Epidemics
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags Biotech and Pharmaceuticals Pandemics US Top News and Analysis
From CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
Tags Zebra Technologies Corp DraftKings Inc Albemarle Corp
From CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
Tags Business News Breaking News: Business Health & Science
From CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
Tags Biogen Inc Biotechnology Epidemics
From CNBC.com News
Stocks making the biggest moves premarket: Kraft Heinz, Paramount, Airbnb, Tripadvisor and more
Tags Airbnb Inc Generac Holdings Inc American Eagle Outfitters Inc
From CNBC.com News
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial
Tags World News Business Disease outbreaks
From CNBC.com News
Stocks making the biggest moves midday: Mission Produce, Nutanix, Alphabet, Tesla and more
Tags Marathon Oil Corp Finance Markets
From CNBC.com News
Stocks making the biggest moves premarket: Tesla, Nutanix, Meta and more
Tags Baker Hughes Co Stock markets Breaking News: Markets
From CNBC.com News
Stocks making the biggest moves midday: CrowdStrike, Horizon Therapeutics, Petco and more
Tags Petco Health and Wellness Company Inc Market Insider State Street Corp
From CNBC.com News
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.